These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38774946)

  • 1. Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy.
    Ming ZH; Zhang YQ; Song L; Chen M; Lin LL; He YY; Liu WL; Zhu YY; Zhang Y; Zhang GJ
    Adv Sci (Weinh); 2024 Aug; 11(29):e2309992. PubMed ID: 38774946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy.
    Ming L; Song L; Xu J; Wang R; Shi J; Chen M; Zhang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35444-35455. PubMed ID: 34292714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly liver-clearable rare-earth core-shell nanoprobe for dual-modal breast cancer imaging in the second near-infrared window.
    Wei Z; Duan G; Huang B; Qiu S; Zhou D; Zeng J; Cui J; Hu C; Wang X; Wen L; Gao M
    J Nanobiotechnology; 2021 Nov; 19(1):369. PubMed ID: 34789288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
    Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
    Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic-guided nanocarriers for ionizing/non-ionizing radiation synergistic treatment against triple-negative breast cancer.
    Zhou Y; Kou J; Zhang Y; Ma R; Wang Y; Zhang J; Zhang C; Zhan W; Li K; Li X
    Biomed Eng Online; 2024 Jul; 23(1):67. PubMed ID: 39003472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
    Chan C; Fonge H; Lam K; Reilly RM
    Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.
    Blaya-Cánovas JL; Griñán-Lisón C; Blancas I; Marchal JA; Ramírez-Tortosa C; López-Tejada A; Benabdellah K; Cortijo-Gutiérrez M; Cano-Cortés MV; Graván P; Navarro-Marchal SA; Gómez-Morales J; Delgado-Almenta V; Calahorra J; Agudo-Lera M; Sagarzazu A; Rodríguez-González CJ; Gallart-Aragón T; Eich C; Sánchez-Martín RM; Granados-Principal S
    Mol Cancer; 2024 May; 23(1):83. PubMed ID: 38730475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer.
    Fang H; Gai Y; Wang S; Liu Q; Zhang X; Ye M; Tan J; Long Y; Wang K; Zhang Y; Lan X
    J Nanobiotechnology; 2021 Mar; 19(1):81. PubMed ID: 33743740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune.
    Jiang Z; Cai G; Liu H; Liu L; Huang R; Nie X; Gui R; Li J; Ma J; Cao K; Luo Y
    J Nanobiotechnology; 2024 May; 22(1):296. PubMed ID: 38811964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor.
    Al-Ejeh F; Shi W; Miranda M; Simpson PT; Vargas AC; Song S; Wiegmans AP; Swarbrick A; Welm AL; Brown MP; Chenevix-Trench G; Lakhani SR; Khanna KK
    J Nucl Med; 2013 Jun; 54(6):913-21. PubMed ID: 23564760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Modality Imaging-Guided Manganese-Based Nanotransformer for Enhanced Gas-Photothermal Therapy Combined Immunotherapeutic Strategy Against Triple-Negative Breast Cancer.
    Guan X; Zeng N; Zhao Y; Huang X; Lai S; Shen G; Zhang W; Wang N; Yao W; Guo Y; Yang R; Wang Z; Jiang X
    Small; 2024 May; 20(22):e2307961. PubMed ID: 38126911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic interventions of Triple Negative Breast Cancer.
    Li Z; Qiu Y; Lu W; Jiang Y; Wang J
    J Transl Med; 2018 May; 16(1):147. PubMed ID: 29848327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.
    Liu L; Wang Y; Miao L; Liu Q; Musetti S; Li J; Huang L
    Mol Ther; 2018 Jan; 26(1):45-55. PubMed ID: 29258739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy.
    Bai L; Liu H; You R; Jiang X; Zhang T; Li Y; Shan T; Qian Z; Wang Y; Liu Y; Li C
    Mol Pharm; 2024 May; 21(5):2148-2162. PubMed ID: 38536949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer.
    Wang Y; Chen Y; Ji DK; Huang Y; Huang W; Dong X; Yao D; Wang D
    J Nanobiotechnology; 2024 Aug; 22(1):461. PubMed ID: 39090622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-Confined Tumor-Docking Reversible Thermogel Potentiates Systemic Antitumor Immune Response During Near-Infrared Photothermal Ablation in Triple-Negative Breast Cancer.
    Revuri V; Rajendrakumar SK; Park MS; Mohapatra A; Uthaman S; Mondal J; Bae WK; Park IK; Lee YK
    Adv Healthc Mater; 2021 Nov; 10(21):e2100907. PubMed ID: 34541833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic MnSe nanobomb with low Mn content activates the cGAS-STING pathway and induces immunogenic cell death to enhance antitumour immunity.
    Gao W; Wang Y; Wang P; Kan W; Wang M; Li H; Wang X; Yuan P; Ma Y; Zhang J; Tian G; Zhang G
    Acta Biomater; 2024 Aug; 184():383-396. PubMed ID: 38936753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1.
    Tan H; Liu J; Huang J; Li Y; Xie Q; Dong Y; Mi Z; Ma X; Rong P
    J Transl Med; 2023 Jul; 21(1):462. PubMed ID: 37438720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.